Skip Navigation

Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer, Phase III

Brief Summary

Breast Cancer

Study Type:
Supportive Care

III Identifier:

Study #:

Start Date:
Feb 27, 2018

Full Details and Eligibility at

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below. ID: NCT03418961

View Complete Trial Details & Eligibility at